Atlanta, GA 5/17/12 (StreetBeat) -- Divine Skin Inc. (OTCBB: DSKX), a leading developer of personal-care products, announced results for its quarter ending March 31, 2012. Net revenue was $1.98 million, compared to $2.25 million in the same quarter of 2011. Gross margin improved significantly, to more than 50 percent or $1.05 million, comparable to last year's quarterly result of $1.10 million. Net loss for the quarter was $428,000, compared to $192,000 for the first quarter of 2011.
Highlights from the first quarter include
• Introduction of API System 9 to physicians
• Two new compounds identified that trigger processes for improved hair growth
• Spectral.F7 study was completed with 15 volunteers showing a significant global improvement in hair counts and density
• A new scalable $1.5 million line of credit
• New distribution by United Natural Foods for the NutraOrigin brand
• Extensive regulatory compliance in preparation for launch in various overseas markets.
• Reformulation of the popular Revita shampoo for superior cosmetic benefits while retaining the well-established therapeutic results.
Divine Skin CEO Daniel Khesin stated, "We are on track to see the kind of explosive growth this year that we have witnessed for last year," he concluded. "In 2012, we are projecting $15 million in revenue. That's more than 50 percent growth over 2011."
"So far this year we have closed new deals for more high-margin products, and we have added several new distribution outlets for all items. Such rapid expansion demands greater marketing and inventory expenditures, but we fully expect these investments to bear fruit in the next few quarters.
Khesin continued, "Our expanding distribution and excellent sell through with existing partners contributes to a robust business with our diverse portfolio of product solutions. Most of the shortfall in first-quarter bookings is mainly due to shipping delays. As our current orders ship, we expect to realize much greater revenue."
About Divine Skin
Divine Skin Inc. leads in the development of biotechnology for topical, nutritional, and pharmaceutical therapies. It markets worldwide through online and specialty retailers, cosmetics wholesalers, salons, and medical offices. The fast-growing company went public in 2009.
DS Laboratories, its flagship brand, offers high-performance topical solutions for a wide range of personal care needs. Bioavailability is enhanced through Nanosome encapsulation (www.dslaboratories.com).
The Sigma Skin brand sells through upscale retailers like Neiman Marcus in the United States and Harvey Nichols in the United Kingdom. The topical products address hair loss and other signs of aging (www.sigmaskin.com).
Polaris Research Laboratories makes high-potency minoxidil-based hair-growth formulas (www.polarisresearchlabs.com).
The Pure Guild offers purity with performance: Botanical compounds proven effective in clinical trials are extracted without industrial solvents or damaging heat and are sold through premium retailers (www.thepureguild.com).
Please contact www.thestreetbeat.com for interest in our latest investor relations platform the “CEO Interview Series” with its host Steve Kanaval. The package includes a one-on-one interview with a seasoned industry professional; published segment to our web site with embedded audio/video file; and a compressed file that can be easily e-mailed out to your current and/or potential investors. Please e-mail email@example.com or call (662) 392-0740 for pricing and scheduling.